Open AccessDo liver metastases from gastric cancer contraindicate aggressive surgical resection? A 14-year single-center experience
Author(s) -
Takefumi Yazawa,
Tomohide Hori,
Hidekazu Yamamoto,
Hideki Harada,
Masafumi Yamamoto,
Masahiro Yamada,
Masaki Tani,
Satoru Asahi,
Yasuyuki Kamada,
Ryouji Tani,
Ryuhei Aoyama,
Y. Sasaki,
Masazumi Zaima
Publication year - 2020
Publication title -
world journal of gastrointestinal pharmacology and therapeutics
Language(s) - English
Resource type - Journals
ISSN - 2150-5349
DOI - 10.4292/wjgpt.v11.i5.110
Subject(s) - medicine , perioperative , surgery , lymphadenectomy , single center , cancer , metastasis , stage (stratigraphy) , paleontology , biology
Advanced gastric cancer (GC) with liver metastasis is often characterized by multiple and bilobular metastases and may also be associated with extrahepatic metastatic lesions. Hence, many physicians consider that radical surgeries are contraindicated for liver metastases from GC (LMGC). According to the 2017 Japanese treatment guideline for GC, a smaller number of liver metastases without unresectable factors may be an indication for liver resection (LR) with curability. The actual 5-year overall survival (OS) rate ranges from 0 to 0.37.